Skip to content

Preoperative Physical Activity Intervention in Patients Before Planned Liver Resection for Cancer (APACHE)

Preoperative Physical Activity Intervention in Patients Before Planned Liver Resection for Cancer

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03518632
Acronym
APACHE
Enrollment
8
Registered
2018-05-08
Start date
2018-03-27
Completion date
2020-03-31
Last updated
2022-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Metastases, Primary Liver Cancer, Secondary Liver Cancer

Keywords

Exercise, Adapted physical activity, preoperative, liver resection, hepatectomy

Brief summary

The aim of this study is to assess the impact of preoperative physical activity on physical capacities of patients undergoing liver resection for primary or secondary liver cancer.

Detailed description

The purpose of this study is to investigate the effects of a preoperative exercise program in patients with primary or secondary liver cancer undergoing hepatectomy. Preoperative exercise programs have been shown to be effective in other cancer populations, but have been poorly studied in patients with liver cancer. For these patients, it remains unclear what the optimal composition of such programs should be and how they should be delivered. Outcome measures in this study will include preoperative outcomes (oxygen consumption, quality of life, fatigue and physical activity level, anthropometric measures, plasma concentrations of hepatokines) and postoperative outcomes (length of hospital stay and postoperative complications). After the study is explained and consent obtained, subjects will be tested on a submaximal exercise on cycloergometer with gas exchanges analysis and with pre and post blood test. Then, they will answer various questionnaires assessing physical activity, quality of life and fatigue. Patients scheduled for liver resection will be randomized to one of two groups. The first group (experimental group) will be subdivided into two groups: interval training 1 and interval training 2, which differentiate themselves by two different intensities.The second group (control group) will receive standard care. The prehabilitation program will last 6 weeks with 3 sessions per week and will consist in two interval training programs on a cycloergometer with two different intensities. One month after surgery, peri and postoperative complications will be noted.

Interventions

BEHAVIORALInterval training

Patients in experimental group will perform a 6 weeks' physical activity program with 3 sessions per week. Physical activity intervention will consist in 2 different interval training programs on cycloergometer: Interval training 1 and Interval training 2, with a difference in exercise intensities.

Patients in control group will follow the standard oncologic care. They will perform only 2 sub-maximal exercises.

Sponsors

Célia Turco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Men and women aged \>18 years old. * Patients with primary liver cancer, biliary tract cancer, liver metastasis endorsed in the University Hospital of Besancon * No opposition of patients * Join a French social security or receiving such a scheme

Exclusion criteria

* Legal incapacity or limited legal capacity * Patients being in the disqualification of another study or under the national register of volunteers * Patients unlikely to cooperate or anticipated low cooperation * Patients with a maximal oxygen consumption above 35 ml/min/kg

Design outcomes

Primary

MeasureTime frameDescription
Change of Oxgen consumption at anaerobic threshold :6 weeksOxygen consumption at anaerobic threshold will be assessed at baseline and at the end of the 6 weeks' program with a submaximal exercise performed on cycloergometer

Secondary

MeasureTime frameDescription
Intensive care stay :One month after surgeryPostoperative intensive care stay will be evaluated (number of days).
Changes of Hepatokines plasmatic concentrations :Comparison between plasmatic concentrations pre-exercise (day 1), post exercise (day 1) and at 6 weeksFetuin A (ng/mL) concentrations will be analyzed.
Hepatokines plasmatic concentrations :Comparison between plasmatic concentrations pre-exercise (day 1), post exercise (day 1) and at 6 weeksFibroblast Growth Factor 21 (FGF21) (pg/mL) concentrations will be analyzed.
Postoperative complications with the Dindo Clavien classification :One month after surgeryPostoperative complications will be assessed using the Dindo Clavien classification which consists in a 7 grades classification (I, II, IIIa, IIIb, IVa, IVb and V).
Changes in Quality of life :Comparison between baseline, after the 6 weeks' programHealth related quality of life will be measured with the EORTC Quality of Life Questionnaire QLQ-C30 which is a cancer specific questionnaire. It consists in 30 items to measure 15 dimensions of quality of life. It generates a score between 0 and 100. A higher score means a higher quality of life level.
Changes in Fatigue :Comparison between baseline, after the 6 weeks' programFatigue will be measured with the Quality of Life Questionnaire QLQ-FA12 which enables to assess cancer related fatigue. It consists in 12 items to measure 5 dimension go health related fatigue. It generates a score between 0 and 100. A higher score means a higher fatigue level.
Changes in Physical activity level :Comparison between baseline, after the 6 weeks' programPhysical activity level will be measured using the long-form of the International Physical Activity Questionnaire (IPAQ). It consist in a description of the physical activity level by assessing 5 activity domains during the 7 last days. Physical activity level is expressed in Metabolic Equivalent Tasks (METs). It enables to classify patients in 3 categories : low physical activity level, moderate physical activity level and high physical activity level.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026